We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Level up your trading with our powerful tools and real-time insights all in one place.
The current PHVS market cap is 906.77M. The company's latest EPS is EUR -2.4631 and P/E is -6.76.
| Quarter End | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 |
|---|---|---|---|---|---|
| EUR (€) | EUR (€) | EUR (€) | EUR (€) | EUR (€) | |
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -28.31M | -40.84M | -37.9M | -45.09M | -42.19M |
| Net Income | -28.02M | -29.73M | -41.71M | -34.76M | -46.34M |
| Year End December 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| EUR (€) | EUR (€) | EUR (€) | EUR (€) | EUR (€) | |
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -25.01M | -54.14M | -86.71M | -96.91M | -145.69M |
| Net Income | -25.99M | -42.73M | -76.33M | -100.88M | -134.22M |
| Quarter End | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 |
|---|---|---|---|---|---|
| EUR (€) | EUR (€) | EUR (€) | EUR (€) | EUR (€) | |
| Total Assets | 377.6M | 351.85M | 313.18M | 291.38M | 248.06M |
| Total Liabilities | 18.43M | 19.08M | 16.39M | 23.61M | 22.73M |
| Total Equity | 359.17M | 332.77M | 296.79M | 267.76M | 225.34M |
| Year End December 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| EUR (€) | EUR (€) | EUR (€) | EUR (€) | EUR (€) | |
| Total Assets | 101.1M | 212.09M | 167.73M | 398.69M | 291.38M |
| Total Liabilities | 5.31M | 7.14M | 18.47M | 14.65M | 23.61M |
| Total Equity | 95.79M | 204.95M | 149.26M | 384.05M | 267.76M |
| Quarter End | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 |
|---|---|---|---|---|---|
| EUR (€) | EUR (€) | EUR (€) | EUR (€) | EUR (€) | |
| Operating | -24.23M | -51.92M | -85.18M | -120.13M | -38.47M |
| Investing | -30k | -71k | -377k | -538k | -161k |
| Financing | 794k | 1.12M | 2.11M | 2.68M | -75k |
| Year End December 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| EUR (€) | EUR (€) | EUR (€) | EUR (€) | EUR (€) | |
| Operating | -21.5M | -44.6M | -67.16M | -93.05M | -120.13M |
| Investing | -43k | -130k | -124k | -90k | -538k |
| Financing | 101.2M | 143.67M | 8.65M | 325.39M | 2.68M |
| Market Cap | 906.77M |
| Price to Earnings Ratio | -6.76 |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 3.23 |
| Price to Book Ratio | 3.39 |
| Dividend Yield | - |
| Shares Outstanding | 54.49M |
| Average Volume (1 week) | 14.79k |
| Average Volume (1 Month) | 63.67k |
| 52 Week Change | -10.49% |
| 52 Week High | 25.4985 |
| 52 Week Low | 11.51 |
| Spread (Intraday) | 17.59 (65.68%) |
| Company Name | Pharvaris NV |
| Address |
emmy noetherweg 2 leiden, south holland 2333 BK |
| Website | https://www.pharvaris.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
